サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1127098

小児ワクチンの世界市場

Pediatric Vaccines: Global Markets
出版日: | 発行: BCC Research | ページ情報: 英文 110 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
小児ワクチンの世界市場
出版日: 2022年09月09日
発行: BCC Research
ページ情報: 英文 110 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の小児ワクチンの市場規模は、2022年の345億米ドルから2027年には502億米ドルに拡大し、2022年から2027年までのCAGRは7.8%と予測されています。

北米市場は、2022年の153億米ドルから2027年には225億米ドルに増加し、2022年から2027年までのCAGRは8.0%と予測されています。アジア太平洋市場は、2022年の75億米ドルから2027年には112億米ドルに増加し、2022年から2027年までのCAGRは8.4%と推定されています。

当レポートでは、世界の小児ワクチンの市場を調査し、市場および技術の概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 技術背景

  • 概要
  • 規制

第4章 市場力学

  • 小児ワクチン市場に影響を与える要因
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第5章 COVID-19パンデミックの影響

  • 疫学
  • 小児ワクチン市場に対するCOVID-19の影響

第6章 小児ワクチン市場： 技術別

  • 世界の小児ワクチン市場：技術別
  • 弱毒生ワクチン
  • 不活化ワクチン
  • サブユニット・組換え・多糖体・コンジュゲートワクチン
  • トキソイドワクチン
  • その他/混合ワクチン

第7章 小児ワクチン市場： 疾患タイプ別

  • 肺炎球菌
  • ジフテリア、破傷風、百日咳
  • MMRV
  • HPV
  • インフルエンザ
  • その他

第8章 小児ワクチン市場： 地域別

  • 世界の小児ワクチン市場：地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 新たな展開

  • 第I相臨床試験
  • 第II相臨床試験
  • 第III相臨床試験

第10章 競合情勢

  • 小児ワクチン企業の市場シェア
  • 戦略的イニシアチブ

第11章 企業プロファイル

  • ABBOTT LABORATORIES
  • ASTRAZENECA PLC
  • BHARAT BIOTECH INTERNATIONAL LTD.
  • CSL SEQIRUS UK LTD.
  • EMERGENT BIOSOLUTIONS INC.
  • GLAXOSMITHKLINE
  • MERCK & CO, INC.
  • PANACEA BIOTEC LTD.
  • PFIZER INC.
  • SANOFI S.A.
  • SERUM INSTITUTE OF INDIA LTD.
  • SINOVAC BIOTECH LTD.
図表

List of Tables

  • Summary Table B : Global Market for Pediatric Vaccines, by Region, Through 2027
  • Summary Table A : Global Market for Pediatric Vaccines, Through 2027
  • Table 1 : Pros and Cons of Attenuated (Live) Vaccines
  • Table 2 : Pros and Cons of Inactivated (Killed) Vaccines
  • Table 3 : Pros and Cons of Toxoid Vaccines
  • Table 4 : Pros and Cons of Subunit Vaccines
  • Table 5 : Pros and Cons of Conjugate Vaccines
  • Table 6 : Pros and Cons of Recombinant Vector Vaccines
  • Table 7 : Pros and Cons, DNA Vaccines
  • Table 8 : Pros and Cons of RNA Vaccines
  • Table 9 : Recommended Vaccinations for Infants and Children (Birth through 6 Years) in the U.S, 2022
  • Table 10 : Recommended Vaccinations for Children Age 7-18, in the U.S., 2022
  • Table 11 : Pediatric/VFC Vaccine Price List, 2022
  • Table 12 : Pediatric Influenza Vaccine Price List, 2022
  • Table 13 : Newly Approved Pediatric Vaccines, January 2019-July 2022
  • Table 14 : COVID-19 Confirmed Cases and Deaths, by WHO Region, as of August 3, 2022
  • Table 15 : Global Market for Pediatric Vaccines, Through 2027
  • Table 16 : Global Market for Pediatric Vaccines, by Technology, Through 2027
  • Table 17 : Global Market for Live Attenuated Pediatric Vaccines, by Region, Through 2027
  • Table 18 : Global Market for Inactivated Pediatric Vaccines, by Region, Through 2027
  • Table 19 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Pediatric Vaccines, by Region, Through 2027
  • Table 20 : Global Market for Toxoid Pediatric Vaccines, by Region, Through 2027
  • Table 21 : Global Market for Other and Combination Pediatric Vaccines, by Region, Through 2027
  • Table 22 : Global Market for Pediatric Vaccines, by Disease Type, Through 2027
  • Table 23 : Global Market for Pneumococcal Pediatric Vaccines, by Region, Through 2027
  • Table 24 : Global Market for Diphtheria, Tetanus and Pertussis Pediatric Vaccines, by Region, Through 2027
  • Table 25 : Global Market for MMRV Pediatric Vaccines, by Region, Through 2027
  • Table 26 : Global Market for HPV Pediatric Vaccines, by Region, Through 2027
  • Table 27 : Global Market for Influenza Pediatric Vaccines, by Region, Through 2027
  • Table 28 : Global Market for Pediatric Vaccines for Other Diseases, by Region, Through 2027
  • Table 29 : Global Market for Pediatric Vaccines, by Region, Through 2027
  • Table 30 : North American Market for Pediatric Vaccines, by Country, Through 2027
  • Table 31 : European Market for Pediatric Vaccines, by Country, Through 2027
  • Table 32 : Asia-Pacific Market for Pediatric Vaccines, by Country, Through 2027
  • Table 33 : Pediatric Vaccines in Phase I Clinical Trials
  • Table 34 : Pediatric Vaccines in Phase II Clinical Trials
  • Table 35 : Vaccines in Phase III and Registration Clinical Trials
  • Table 36 : Pfizer: Financial Performance, 2019-2021

List of Figures

  • Summary Figure A : Global Market for Pediatric Vaccines, 2020-2027
  • Summary Figure B : Global Market for Pediatric Vaccines, by Region, 2020-2027
  • Figure 1 : Global Vaccination Coverage, by Vaccine, 2021
  • Figure 2 : Vaccine Timeline, Since 1800s
  • Figure 3 : Number of Countries with Childhood Vaccination Policies, by Vaccination Classification, 2021
  • Figure 4 : Global Market for Pediatric Vaccines, by Technology, 2020-2027
  • Figure 5 : Global Market Share for Pediatric Vaccines, by Technology, 2021
  • Figure 6 : Global Market for Live-Attenuated Pediatric Vaccines, by Region, 2020-2027
  • Figure 7 : Global Market for Inactivated Pediatric Vaccines, by Region, 2020-2027
  • Figure 8 : Global Market for Subunit, Recombinant, Polysaccharide and Conjugate Pediatric Vaccines, by Region, 2020-2027
  • Figure 9 : Global Market for Toxoid Pediatric Vaccines, by Region, 2020-2027
  • Figure 10 : Global Market for Other and Combination Pediatric Vaccines, by Region, 2020-2027
  • Figure 11 : Global Market for Pediatric Vaccines, by Disease Type, 2020-2027
  • Figure 12 : Global Market Share for Pediatric Vaccines, by Disease Type, 2021
  • Figure 13 : Global Market for Pneumococcal Pediatric Vaccines, by Region, 2020-2027
  • Figure 14 : Global Market for Diphtheria, Tetanus and Pertussis Pediatric Vaccines, by Region, 2020-2027
  • Figure 15 : Global Market for MMRV Pediatric Vaccines, by Region, 2020-2027
  • Figure 16 : Countries with HPV Vaccine in the National Immunization Schedule, by Income Group, 2020
  • Figure 17 : Global Market for HPV Pediatric Vaccines, by Region, 2020-2027
  • Figure 18 : Global Market for Influenza Pediatric Vaccines, by Region, 2020-2027
  • Figure 19 : Global Market for Pediatric Vaccines for Other Diseases, by Region, 2020-2027
  • Figure 20 : Global Market for Pediatric Vaccines, by Region, 2020-2027
  • Figure 21 : Shares of Global Market for Pediatric Vaccines, by Region, 2021
  • Figure 22 : North American Market for Pediatric Vaccines, by Country, 2020-2027
  • Figure 23 : U.S. Market for Pediatric Vaccines, 2020-2027
  • Figure 24 : Canadian Market for Pediatric Vaccines, 2020-2027
  • Figure 25 : European Market for Pediatric Vaccines, by Country, 2020-2027
  • Figure 26 : German Market for Pediatric Vaccines, 2020-2027
  • Figure 27 : U.K. Market for Pediatric Vaccines, 2020-2027
  • Figure 28 : French Market for Pediatric Vaccines, 2020-2027
  • Figure 29 : Italian Market for Pediatric Vaccines, 2020-2027
  • Figure 30 : Spanish Market for Pediatric Vaccines, 2020-2027
  • Figure 31 : Rest of Europe Market for Pediatric Vaccines, 2020-2027
  • Figure 32 : Asia-Pacific Market for Pediatric Vaccines, by Country, 2020-2027
  • Figure 33 : Chinese Market for Pediatric Vaccines, 2020-2027
  • Figure 34 : Japanese Market for Pediatric Vaccines, 2020-2027
  • Figure 35 : Indian Market for Pediatric Vaccines, 2020-2027
  • Figure 36 : Rest of Asia-Pacific Market for Pediatric Vaccines, 2020-2027
  • Figure 37 : RoW Market for Pediatric Vaccines, 2020-2027
  • Figure 38 : Shares of Global Market for Pediatric Vaccines, by Company, 2021
  • Figure 39 : Abbott Laboratories: Net Revenue, 2019-2021
  • Figure 40 : Abbott Laboratories: Revenue Share, by Business Segment, 2021
  • Figure 41 : Abbott Laboratories: Revenue Share, by Country, 2021
  • Figure 42 : AstraZeneca: Net Revenue, 2019-2021
  • Figure 43 : AstraZeneca: Revenue Share, by Business Segment, 2021
  • Figure 44 : AstraZeneca: Revenue Share, by Region, 2021
  • Figure 45 : CSL Ltd. (Seqirus): Net Revenue, 2019-2021
  • Figure 46 : CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
  • Figure 47 : Emergent BioSolutions: Net Revenue, 2019-2021
  • Figure 48 : GlaxoSmithKline: Net Revenue, 2019-2021
  • Figure 49 : GlaxoSmithKline: Revenue Share, by Business Segment, 2021
  • Figure 50 : GlaxoSmithKline: Revenue Share, by Region, 2021
  • Figure 51 : Merck & Co.: Annual Revenue, 2019-2021
  • Figure 52 : Merck & Co.: Revenue Share, by Business Segment, 2021
  • Figure 53 : Merck & Co.: Revenue Share, by Region, 2021
  • Figure 54 : Pfizer: Annual Revenue, 2019-2021
  • Figure 55 : Pfizer: Net Sales Share, by Business Segment, 2021
  • Figure 56 : Pfizer: Net Sales Share, by Region, 2021
  • Figure 57 : Sanofi SA: Net Revenue, 2019-2021
  • Figure 58 : Sanofi SA: Revenue Share, by Business Segment, 2021
  • Figure 59 : Sanofi SA: Revenue Share, by Region, 2021
目次
Product Code: PHM265A

Highlights:

The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.

North American pediatric vaccines market should reach $15.3 billion by 2022 and more than $22.5 billion by 2027, with a CAGR of 8.0% during the forecast period of 2022-2027.

Asia-Pacific pediatric vaccines market should reach $7.5 billion by 2022 and more than $11.2 billion by 2027, with a CAGR of 8.4% during the forecast period of 2022-2027.

Report Scope:

This report highlights the current and future market potential of pediatric vaccines and a detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections through 2027 and estimates market shares for key players, as well as pediatric vaccines by type and by application. The report also discusses the impact of the COVID-19 pandemic on this market.

Report Includes:

  • 21 data tables and 17 additional tables
  • A comprehensive overview of the current and future global markets for pediatric vaccines
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size for pediatric vaccines in USD million values, market forecast and corresponding market share analysis by technology, disease type (application), and geographic region
  • Highlights of the key growth driving factors and constraints that will shape the market for pediatric vaccines as the basis for projecting demand over the forecast period (2022-2027)
  • In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and other macroeconomics factors affecting the marketplace
  • Highlights of the COVID-19 impact on the global pediatric vaccines market, with pandemic implications on demand/supply of vaccines across the world, and govt. strategic decisions to boost the marketplace
  • Emphasis on the new developments in the pediatric vaccines market, and underlying clinical trials for all phases and list of vaccines
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
  • Company profiles of major players within the industry, including Pfizer, Abbott Laboratories, Merck & Co., GlaxoSmithKline, Sanofi SA and AstraZeneca

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing this Study
  • 1.3 Scope of Report
  • 1.4 Information Sources
  • 1.5 Methodology
  • 1.6 Geographic Breakdown
  • 1.7 Analyst's Credentials
  • 1.8 BCC Custom Research
  • 1.9 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Technology Background

  • 3.1 Introduction
    • 3.1.1 History of Vaccine Development
    • 3.1.2 Types of Vaccines
    • 3.1.3 Attenuated (Live) Vaccines
    • 3.1.4 Inactivated (Killed) Vaccines
    • 3.1.5 Toxoid Vaccines
    • 3.1.6 Subunit Vaccines
    • 3.1.7 Conjugate Vaccines
    • 3.1.8 Recombinant Vector Vaccines
    • 3.1.9 DNA Vaccines
    • 3.1.10 RNA Vaccines
    • 3.1.11 Childhood Vaccination Policies
    • 3.1.12 Pediatric Immunization
  • 3.2 Regulatory Aspects
    • 3.2.1 New Product Approvals

Chapter 4 Market Dynamics

  • 4.1 Factors Affecting the Pediatric Vaccine Market
  • 4.2 Market Drivers
    • 4.2.1 Increasing Awareness and Government Support
    • 4.2.2 Growing Investments and R&D
    • 4.2.3 Product Approvals and Launches
    • 4.2.4 Collaboration Agreements
    • 4.2.5 Increasing Burden of Diseases
  • 4.3 Market Restraints
    • 4.3.1 Investment and Pricing
  • 4.4 Market Opportunities
    • 4.4.1 Increased Demand from Emerging Markets

Chapter 5 Impact of COVID-19 Pandemic

  • 5.1 Introduction
  • 5.2 Epidemiology
  • 5.3 Impact of COVID-19 on the Pediatric Vaccine Market

Chapter 6 Pediatric Vaccine Market, by Technology

  • 6.1 Global Market for Pediatric Vaccines, by Technology
  • 6.2 Live Attenuated Vaccines
  • 6.3 Inactivated Vaccines
  • 6.4 Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
  • 6.5 Toxoid Vaccines
  • 6.6 Other/Combination Vaccines

Chapter 7 Pediatric Vaccine Market, by Disease Type

  • 7.1 Pneumococcal
  • 7.2 Diphtheria, Tetanus and Pertussis
  • 7.3 MMRV
  • 7.4 HPV
  • 7.5 Influenza
  • 7.6 Other Diseases

Chapter 8 Pediatric Vaccine Market, by Region

  • 8.1 Global Market for Pediatric Vaccines, by Region
  • 8.2 North America
    • 8.2.1 United States
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 United Kingdom
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia-Pacific
  • 8.5 Rest of the World

Chapter 9 New Developments

  • 9.1 Phase I Clinical Trials
  • 9.2 Phase II Clinical Trials
  • 9.3 Phase III Clinical Trials

Chapter 10 Competitive Landscape

  • 10.1 Market Shares of Pediatric Vaccine Companies
  • 10.2 Strategic Initiatives

Chapter 11 Company Profiles

  • ABBOTT LABORATORIES
  • ASTRAZENECA PLC
  • BHARAT BIOTECH INTERNATIONAL LTD.
  • CSL SEQIRUS UK LTD.
  • EMERGENT BIOSOLUTIONS INC.
  • GLAXOSMITHKLINE
  • MERCK & CO, INC.
  • PANACEA BIOTEC LTD.
  • PFIZER INC.
  • SANOFI S.A.
  • SERUM INSTITUTE OF INDIA LTD.
  • SINOVAC BIOTECH LTD.